Leukemia Review
 
Introduction

  Measuring WBCs

  Myeloid Leukemias   Lymphoid Leukemias Sources of Error

Quiz Please


Clinical problems and outcome for patients with CLL.
  • For most it is an indolent course with median survival of 4-6 years.
    • Survivals as long as 10 years are not uncommon.
  • Common nondescript symptoms include: 
    • Malaise,  weight loss, fever, night sweats and complaints relative to various cytopenias.
  • Many patients have hypogammaglobulinemia leading to infections.
  • Up to 15% develop renegade antibodies against self constituents.
    • Autoimmune hemolytic anemia.
    • Autoimmune thrombocytopenia.
  • Some patients experience a transformation of the CLL to a higher grade malignancy.
    • Prolymphocytic transformation: larger and less well differentiated lymphocytes appear in circulation. This is a bit like the accelerated phase of CML.
    • Richter's syndrome: transformation to a diffuse large B-cell lymphoma.
    • Both of these "accelerated" phases of CLL are bad signs, and most people die within one year of their development.
  • Some patients develop an aplastic anemia.
Treatment.                                                                                     Back

Main Index | Slide Table of Contents | Case Studies Table of Contents